SCHEMBL20819684

SCHEMBL20819684

Cc1cc(O)c(C2(C(=O)O)CC2)c(O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SELL P14151 1/20 0.39
▸ SELP P16109 1/20 0.39
▸ SELE P16581 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ CSNK2A1 P68400 1/20 0.38
▸ HDAC4 P56524 1/20 0.36
▸ TPMT P51580 1/20 0.35
▸ HCAR1 Q9BXC0 1/20 0.35
▸ AKR1C1 Q04828 2/20 0.35
▸ AKR1B10 O60218 1/20 0.35
▸ AKR1C4 P17516 1/20 0.35
▸ AKR1C3 P42330 1/20 0.35
▸ AKR1C2 P52895 1/20 0.35
▸ CYP2C19 P33261 3/20 0.33
▸ APP P05067 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ PIM1 P11309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20819590 0.85 ALDH1A1 (0.41) ACHETPMTKDM4EKMT2A
SCHEMBL4711506 0.76 CSNK2A1 (0.43) CSNK2A1AKR1C1AKR1B10AKR1C4AKR1C3
SCHEMBL20819588 0.76 ALDH1A1 (0.45) ACHEKMT2A
SCHEMBL28681478 0.75 AKR1C1 (0.45) HDAC4TPMTAKR1C1AKR1B10AKR1C4
SCHEMBL17321011 0.73 HCAR1 (0.46) HDAC4TPMTHCAR1AKR1C1AKR1B10
SCHEMBL20819570 0.72 KMT2A (0.38) CYP3A4KMT2A
SCHEMBL20819553 0.72 ALDH1A1 (0.41) ACHEKMT2A
SCHEMBL20819544 0.71 CYP26A1 (0.38) ACHEAKR1C1AKR1B10AKR1C4AKR1C3
SCHEMBL1561226 0.69 HDAC4 (0.59) HDAC4AKR1C1AKR1B10AKR1C4AKR1C3
SCHEMBL27463878 0.68 HCAR2 (0.47) HDAC4AKR1C1AKR1B10AKR1C4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681864-A1 MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE AbbVie Overseas S.à r.l. (LU) 2020-07-22 — — EP disclosed
WO-2019053634-A1 MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE AbbVie S.à.r.l. (LU) 2019-03-21 — — WO disclosed
Send feedback